RESUMO
Objective: To investigate the clinicopathological features of adult orbital xanthogranulomatous disease (AOXGD) with lacrimal gland reactive lymphoid hyperplasia. Methods: Retrospective case series study. The clinical and pathological data of AOXGD cases diagnosed and treated in Tianjin Eye Hospital from January 2002 to December 2021 was reviewed, and the clinical characteristics, radiologic findings and pathological characteristics of periocular and lacrimal gland lesions of 5 cases were retrospectively analyzed. The expression of IgG4 and IgG protein in periocular and lacrimal gland lesions was detected by immunohistochemical staining, and the role of IgG4 in AOXGD was preliminarily studied. Results: There were four females and one male with an average age of 53.8 years (39 to 77 years). Among the five AOXGD cases, there were three cases of adult-onset xanthogranuloma, one case of adult-onset asthma and periocular xanthogranuloma, and one case of necrobiotic xanthogranuloma. All cases involved both eyes. The swelling of eyelids was observed in five cases, and the yellow or pale yellow eyelid skin was found in two cases. Imaging examinations showed the tumor mainly involved the eyelids, subcutaneous tissues, anterior orbit and lacrimal gland. A large number of foam cells and typical Touton giant cells were found in the periorbital lesions, accompanied by different degrees of fibrosis. The fibrinoid necrosis was detected in one case of necrobiotic xanthogranuloma. The lacrimal gland lesions showed different types of reactive lymphoid hyperplasia, including IgG4-related disease in two cases, follicular lymphoid hyperplasia in two cases and focal lymphoid hyperplasia in one case. IgG4 levels of periorbital and lacrimal gland lesions were elevated in four cases. Asthma and elevated serum IgG4 were found in one case of adult-onset periocular xanthogranuloma. Three patients underwent surgical resection and adjuvant hormone or immunosuppressive therapy, and two patients underwent simple surgical resection. The patients were followed up for 1.5 to 10.0 years, one patient was lost, and four patients had no recurrence. Conclusions: AOXGD with lacrimal gland reactive lymphoid hyperplasia is a group of rare diseases. The periorbital lesions of that are characterized by proliferation of foamy histiocytes and Touton giant cells, and the lacrimal gland lesions of that manifest as IgG4-related disease in some cases.
Assuntos
Asma , Doença Relacionada a Imunoglobulina G4 , Aparelho Lacrimal , Xantogranuloma Necrobiótico , Doenças Orbitárias , Pseudolinfoma , Xantomatose , Adulto , Asma/complicações , Asma/patologia , Feminino , Humanos , Hiperplasia/complicações , Hiperplasia/patologia , Imunoglobulina G , Aparelho Lacrimal/patologia , Masculino , Pessoa de Meia-Idade , Xantogranuloma Necrobiótico/diagnóstico , Xantogranuloma Necrobiótico/patologia , Xantogranuloma Necrobiótico/terapia , Doenças Orbitárias/terapia , Pseudolinfoma/complicações , Pseudolinfoma/patologia , Estudos Retrospectivos , Xantomatose/diagnósticoRESUMO
Necrobiotic xanthogranuloma (NXG) is a rare non-Langerhans cell histiocytosis with characteristic cutaneous features and rare visceral involvement. More than 80% of individuals with this disease have a detectable paraprotein but the precise pathogenesis remains obscure. A 68-year-old man with known cutaneous necrobiotic xanthogranuloma presented with acute kidney injury and imaging suggestive of bilateral perinephric infiltration. Renal biopsy showed a prominent histiocytic infiltration of renal capsule and cortex with necrobiosis and characteristic 'Touton-type' giant cells suggestive of necrobiotic xanthogranuloma involvement. Kidney function returned to normal and cutaneous lesions improved with a combination of corticosteroid, chlorambucil and rituximab. This case represents only the second reported incidence of kidney involvement by necrobiotic xanthogranuloma and the first with acute kidney injury and pre-mortem histopathology. This report adds to a small body of literature on the diagnosis and management of visceral involvement by this rare disease.
Assuntos
Injúria Renal Aguda , Xantogranuloma Necrobiótico , Paraproteinemias , Idoso , Biópsia , Humanos , Rim/patologia , Masculino , Xantogranuloma Necrobiótico/diagnóstico , Xantogranuloma Necrobiótico/tratamento farmacológico , Xantogranuloma Necrobiótico/patologia , Paraproteinemias/complicações , Paraproteinemias/diagnósticoRESUMO
We report the case of a 57-year-old man who presented with a 6-year history of yellowish plaques on his left buttock and right medial knee, as well as ulcerating subcutaneous nodules on his forearms bilaterally. Skin biopsy, bone biopsy, and serum protein electrophoresis confirmed the diagnosis of necrobiotic xanthogranuloma with associated monoclonal gammopathy. Necrobiotic xanthogranuloma is a rare form of non-Langerhans histiocytosis characterized by development of chronic cutaneous nodules that enlarge over time to form plaques. The author discusses necrobiotic xanthogranuloma's presentation and the utility of F-FDG PET/CT in disease staging, localizing optimal biopsy sites, and assessing treatment response.
Assuntos
Fluordesoxiglucose F18 , Xantogranuloma Necrobiótico/diagnóstico por imagem , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada , Biópsia , Humanos , Masculino , Pessoa de Meia-Idade , Xantogranuloma Necrobiótico/patologia , Estadiamento de NeoplasiasRESUMO
Necrobiotic xanthogranuloma is a rare chronic condition, belonging to the group C non-Langerhans cell histiocytoses, which is relevant due to the possibility of extracutaneous involvement and association with systemic diseases, particularly hematologic malignancies. The case reported here was only diagnosed after nine years of evolution and was associated with plasma cell dyscrasia. After treatment with cyclophosphamide, dexamethasone, and thalidomide, there was a reduction of cutaneous lesions and serum levels of monoclonal protein.
Assuntos
Xantogranuloma Necrobiótico/tratamento farmacológico , Mieloma Múltiplo Latente/tratamento farmacológico , Ciclofosfamida/uso terapêutico , Dexametasona/uso terapêutico , Feminino , Humanos , Imunossupressores/uso terapêutico , Pessoa de Meia-Idade , Xantogranuloma Necrobiótico/complicações , Xantogranuloma Necrobiótico/patologia , Mieloma Múltiplo Latente/complicações , Mieloma Múltiplo Latente/patologia , Talidomida/uso terapêutico , Resultado do TratamentoRESUMO
Granulomatous dermatoses comprise a wide range of etiologically and clinically distinct skin diseases that share a common histology characterized by the accumulation of histiocytes include macrophages. While the pathogenesis of these disorders is not fully understood, the underlying mechanism is thought to involve a reaction pattern caused by an immunogenic stimulus. Antigen-presenting cells and the effect of various cytokines play a key role. Our understanding of granulomatous reaction patterns has been advanced by insights drawn from observations of such reactions in patients on immunomodulatory therapy and in individuals with genetic immunodeficiency. Traditionally, a distinction is made between infectious and non-infectious granulomatous dermatoses. The present CME article addresses granulomatous skin diseases for which there is no evidence of a causative infectious agent. Common representatives include granuloma annulare, necrobiosis lipoidica and cutaneous sarcoidosis. Granulomatous dermatoses may be part of the clinical spectrum of various systemic disorders or may be associated therewith. Some neoplastic disorders may mimic granulomatous dermatoses histologically. Given the pathogenetic diversity involved, the clinical presentation, too, is quite varied. Overall, however, each disorder is characterized by typical clinical features. The diagnosis always requires thorough clinicopathologic correlation. Treatment is preferably based on the underlying pathogenesis and frequently involves anti-inflammatory agents. In most cases, however, there is insufficient study data. The dermal nature of these disorders frequently poses a therapeutic challenge, especially with respect to topical treatment.
Assuntos
Granuloma/patologia , Dermatopatias/patologia , Doença de Crohn/patologia , Dermatite Alérgica de Contato/patologia , Diagnóstico Diferencial , Reação a Corpo Estranho/patologia , Granuloma Anular/patologia , Histiócitos/patologia , Humanos , Necrobiose Lipoídica/patologia , Xantogranuloma Necrobiótico/patologia , Doenças não Transmissíveis , Doenças da Imunodeficiência Primária/patologia , Rosácea/patologia , Sarcoidose/patologia , Neoplasias Cutâneas/patologiaRESUMO
Abstract: Necrobiotic xanthogranuloma is a rare chronic condition, belonging to the group C non-Langerhans cell histiocytoses, which is relevant due to the possibility of extracutaneous involvement and association with systemic diseases, particularly hematologic malignancies. The case reported here was only diagnosed after nine years of evolution and was associated with plasma cell dyscrasia. After treatment with cyclophosphamide, dexamethasone, and thalidomide, there was a reduction of cutaneous lesions and serum levels of monoclonal protein.
Assuntos
Humanos , Feminino , Pessoa de Meia-Idade , Xantogranuloma Necrobiótico/tratamento farmacológico , Mieloma Múltiplo Latente/tratamento farmacológico , Talidomida/uso terapêutico , Dexametasona/uso terapêutico , Resultado do Tratamento , Ciclofosfamida/uso terapêutico , Xantogranuloma Necrobiótico/complicações , Xantogranuloma Necrobiótico/patologia , Mieloma Múltiplo Latente/complicações , Mieloma Múltiplo Latente/patologia , Imunossupressores/uso terapêuticoAssuntos
Gamopatia Monoclonal de Significância Indeterminada/diagnóstico , Xantogranuloma Necrobiótico/diagnóstico , Biópsia , Extremidades , Humanos , Masculino , Pessoa de Meia-Idade , Gamopatia Monoclonal de Significância Indeterminada/complicações , Xantogranuloma Necrobiótico/etiologia , Xantogranuloma Necrobiótico/patologia , Pele/patologia , TroncoRESUMO
Histiocytoses, including Langerhans cell histiocytosis (LCH), juvenile or adult xanthogranuloma (AXG) and Rosai-Dorfman disease (RDD), are rare disorders characterized by the proliferation of cells derived from monocyte/macrophage lineages. A few cases of LCH coexisting with xanthogranuloma or RDD have been reported. The etiology of these diseases remains unclear. However, oncogenic BRAFV 600E mutations have been identified in LCH. Here, we report the case of a 26-year-old Japanese man with a 3-month history of a solitary occipital nodule. No abnormality was detected in his other organs, and a total resection of the nodule was performed. Histopathological examination revealed the coexistence of LCH and AXG with prominent emperipolesis characteristic of RDD. Immunohistochemistry showed that most of the large histiocytes were positive for CD68, weakly positive or negative for S100, and negative for CD207 and CD1a, supporting the diagnosis of AXG. The tumor cells with emperipolesis did not show S100-positive findings characteristic of RDD. The focally aggregated oval histiocytic cells were positive for CD1a, CD207, CD68 and S100, and were compatible with the immunophenotype of LCH cells. In addition, these cells were positive for BRAFV 600E mutation. The tumor cells in our patient exhibited a cellular morphology characteristic of multiple histiocytoses in a solitary cutaneous nodule, which may imply an etiological association among LCH, AXG and RDD. To our knowledge, this is the first report of a BRAFV 600E mutation-positive case of LCH coexisting with AXG. Because patients with BRAFV 600E mutation have higher risks of multisystemic LCH and recurrence, we should carefully follow up the patient.
Assuntos
Histiocitose de Células de Langerhans/diagnóstico , Células de Langerhans/patologia , Xantogranuloma Necrobiótico/diagnóstico , Proteínas Proto-Oncogênicas B-raf/genética , Adulto , Histiocitose de Células de Langerhans/complicações , Histiocitose de Células de Langerhans/genética , Histiocitose de Células de Langerhans/patologia , Humanos , Masculino , Xantogranuloma Necrobiótico/complicações , Xantogranuloma Necrobiótico/genética , Xantogranuloma Necrobiótico/patologiaAssuntos
Descompressão Cirúrgica/métodos , Doenças Palpebrais/patologia , Xantogranuloma Necrobiótico/patologia , Xantogranuloma Necrobiótico/terapia , Prednisona/uso terapêutico , Biópsia por Agulha , Doenças Palpebrais/tratamento farmacológico , Feminino , Seguimentos , Humanos , Imuno-Histoquímica , Pessoa de Meia-Idade , Xantogranuloma Necrobiótico/diagnóstico por imagem , Medição de Risco , Índice de Gravidade de Doença , Tomografia Computadorizada por Raios X/métodos , Resultado do TratamentoAssuntos
Cicatriz/patologia , Dissecação/métodos , Glucocorticoides/administração & dosagem , Xantogranuloma Necrobiótico , Pele/patologia , Abdome , Adulto , Dorso , Biópsia/métodos , Diagnóstico Diferencial , Humanos , Masculino , Xantogranuloma Necrobiótico/diagnóstico , Xantogranuloma Necrobiótico/patologia , Xantogranuloma Necrobiótico/terapia , Recidiva , Coxa da Perna , Resultado do TratamentoAssuntos
Inibidores da Angiogênese/uso terapêutico , Fármacos Dermatológicos/uso terapêutico , Fatores Imunológicos/uso terapêutico , Xantogranuloma Necrobiótico/tratamento farmacológico , Talidomida/análogos & derivados , Idoso , Feminino , Humanos , Lenalidomida , Xantogranuloma Necrobiótico/patologia , Talidomida/uso terapêuticoAssuntos
Hepatopatias/diagnóstico por imagem , Fígado/diagnóstico por imagem , Xantogranuloma Necrobiótico/diagnóstico por imagem , Dexametasona/uso terapêutico , Quimioterapia Combinada , Feminino , Humanos , Lenalidomida/uso terapêutico , Hepatopatias/tratamento farmacológico , Imageamento por Ressonância Magnética , Pessoa de Meia-Idade , Xantogranuloma Necrobiótico/tratamento farmacológico , Xantogranuloma Necrobiótico/patologia , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada , Pele/patologia , Dermatopatias/patologiaRESUMO
The palisading granulomatous dermatitides comprise a group of different skin diseases with similar histomorphologic forms of granuloma in the skin. Histopathologically characteristic are areas in the reticular dermis and subcutaneous fat with degenerated bundles of collagen surrounded by histiocytes and multinucleate giant cells aligned in a palisade (necrobiotic granuloma). Within the center of palisaded granulomas, mucin or fibrin can be found. The skin diseases presenting histologically with palisading granuloma are granuloma annulare and necrobiosis lipoidica. Palisading granuloma may also be an expression of systemic disease in rheumatoid nodules and necrobiotic xanthogranuloma. Little is known about the pathogenesis. The clinical presentation of the diseases is variable. Therapy is challenging and may not be satisfying.
Assuntos
Dermatite/diagnóstico , Granuloma Anular/diagnóstico , Necrobiose Lipoídica/diagnóstico , Xantogranuloma Necrobiótico/diagnóstico , Nódulo Reumatoide/diagnóstico , Biópsia , Colágeno/metabolismo , Dermatite/patologia , Derme/patologia , Diagnóstico Diferencial , Granuloma Anular/patologia , Humanos , Mucinas/metabolismo , Necrobiose Lipoídica/patologia , Xantogranuloma Necrobiótico/patologia , Remissão Espontânea , Nódulo Reumatoide/patologia , Pele/patologia , Gordura Subcutânea/patologiaRESUMO
Clinical manifestations of granulomatous diseases are a recurring challenge in everyday dermatological practice. Clinical presentation and histological patterns are variable, depending on the particular disease. Knowledge about the differential diagnosis of granulomatous changes in the face is of decisive importance for making a rational diagnosis and therapy considering the patient's well-being. Therefore, histological and clinical characteristics of important granulomatous diseases that typically manifest on the face are presented here.